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Health system, public health, and economic
implications of managing COVID-19 from a
cardiovascular perspective
Background
The COVID-19 outbreak continues to spread internationally. After ini-
tial outbreaks have been supressed for now in China and South Korea,
the virus continues to spread at an alarming rate throughout Europe.1
At the time of writing, a quarter of the world is in some form of lock-
down. We consider not just the short-term effects of COVID-19, but
also medium to long-term effects. We conclude that the health system
and economic impacts of COVID-19 may be exacerbated by lost
opportunities for primary and secondary prevention. We suggest that
in order to mitigate against this risk, public health messages are devel-
oped which are co-beneficial to protect against COVID-19 and the pri-
mary and secondary prevention of cardiovascular disease.
Health system impact
In the short term, the capacity issues created by COVID-19 will affect
quality of care, leaving patients more vulnerable to complications of
cardiovascular disease. At times of increased demand, access to critical
care services will be rationed. The ability to initiate treatments even
for cardiovascular emergencies such as an ST-segment elevation myo-
cardial infarction (STEMI) may be limited due to risks to staff, work-
force pressures, and the need for prolonged post-procedural cleaning
in potential cases of COVID-19. Guidelines may be adjusted to include
less effective treatments. In China, guidelines for acute coronary syn-
drome shifted away from percutaneous coronary intervention (PCI) in
all patients, regardless of COVID-19 status.2 Such deviations from
optimal care will lead to increases in cardiovascular mortality and
morbidity. Strategic planning is needed to maintain the provision of
best-practice emergency care for as long as is possible. This includes
ensuring a safe environment within the cardiac catheterization lab, the
provision of adequate personal protective equipment, and only trans-
ferring patients between hospitals when necessary.
Until we develop an exit strategy, modelling indicates that COVID-
19 will go through cycles of acceleration, suppression, and re-
emergence for up to 12 months.3 At times of increased demand,
non-essential elective and semi-elective procedures will be postponed.
The Centers for Medicare & Medicaid Services (CMS) in the USA has
already issued guidance recommending that hospitals consider post-
poning elective angioplasty during the COVID-19 pandemic.4 It is pos-
sible that patients on waiting lists will develop otherwise avoidable
complications that will increase the demand on healthcare services in
the future. Proactive forward planning is needed to capitalize upon
periods of relative suppression of COVID-19 to clear waiting lists.
Prioritization must be given to those with the highest clinical need.
Public health impact
In the medium to long term, the lifestyle and mental health consequen-
ces of COVID-19 may increase the burden of cardiovascular disease.
First, social distancing measures promote sedentary behaviour, and
sudden shifts in lifestyle may lead to unhealthy diets. As social distanc-
ing measures may exist for several months, this will limit opportunities
for the primary and secondary prevention of cardiovascular disease.
Sedentary behaviour can have relatively fast-onset effects due to sud-
den changes in insulin sensitivity. Just 3 days of inactivity is associated
with significantly higher post-prandial glucose concentrations.5
Secondly, the uncertainty and lifestyles changes associated with
COVID-19 cause significant stress and anxiety. Social distancing meas-
ures, in particular, may lead to worsening depression and loneliness.
Stressful and sudden events, such as natural disasters, have been
shown to be associated with increased incidence of cardiovascular
events.6 Stress and anxiety have also been shown to have an adverse
effect on blood pressure and glycaemic control,7,8 and compliance
with medications.9 Thirdly, social distancing and increased demand for
healthcare services due to COVID-19 will limit opportunities for
appointments with cardiologists and primary care physicians responsi-
ble for the screening and management of modifiable cardiovascular
risk factors. This may have minimal effects in the short term, but in the
medium to long term this will increase demand on healthcare services.
Economic impact
To combat COVID-19, healthcare systems require immediate injec-
tions of public funds to purchase equipment, pay extra staff, and build
temporary hospitals. In addition, competition for resources such as
ventilators and personal protective equipment is increasing prices. To
compensate for increased government borrowing and because of the
wider economic impact of COVID-19, there is a danger that a new
period of austerity will begin post-pandemic. This will depend upon
the unique context in each country. Many countries are beginning to
understand that prolonged austerity has left their healthcare systems
vulnerable to major shocks such as this pandemic. However, the ability
to maintain health spending growth is also dependent on the state of
each country’s economy post-pandemic.
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COVID-19 will also lead to long-lasting economic effects on health
systems by increasing future demand for healthcare services: (i)
because of the necessary resources needed to clear the backlog of
postponed elective and semi-elective procedures; (ii) due to the
increased burden of disease driven by negative lifestyle changes and
poorer mental health; and (iii) because of many lost opportunities for
primary and secondary prevention of cardiovascular disease which are
known to be cost-effective. A systematic review of interventions to
prevent and control diabetes found that many interventions including
screening, treatment of hypertension, treatment of diabetes-related
complications, or educational programmes were not just cost-
effective, but often cost-saving.10 Case-finding strategies for the pri-
mary prevention of cardiovascular disease in high-risk individuals has
also been found to be cost-effective.11 Cardiac rehabilitation is also
known as a cost-effective strategy for secondary prevention of cardio-
vascular disease.12
Public health responses
One way to reduce the total health impact of COVID-19 is to develop
public health messages which are co-beneficial for protecting against
COVID-19 and encouraging the primary and secondary prevention of
cardiovascular disease. This will also minimize the economic impact of
COVID-19 on health systems.
Smoking cessation
First, aside from its beneficial cardiovascular effects, public health mes-
sages should emphasize how smoking increases the risk of poorer out-
comes if infected by COVID-19. A systematic review suggests that
smokers are more likely to require critical care admission and have
higher mortality rates.13 This is particularly important in countries such
as China, where almost half of men smoke.14 Smokers may also be at
increased risk of being infected with COVID-19. It has been shown
that smoking increases the rate of transmission of respiratory syncytial
virus.15 Health shocks are known to increase the likelihood of success-
fully quitting smoking.16 Therefore, COVID-19 presents a significant
opportunity to promote smoking cessation.
Promoting healthy lifestyles
Secondly, to prevent sedentary behaviour, regular exercise and healthy
diets should be promoted. Public health messages should emphasize
how regular exercise can improve respiratory capacity, protect mental
health, and maintain a healthy weight. Obesity is a known risk factor
for admission to critical care and mortality in patients with COVID-
19.17 Knowing this might encourage some patients to lose weight or
engage with weight management programmes which can be coordi-
nated remotely through apps. For secondary prevention, a systematic
review revealed no difference in effectiveness between home-based
vs. supervised cardiac rehabilitation.18 Therefore, there is no rationale
to restrict access to cardiac rehabilitation services by patients during
the COVID-19 pandemic. If anything, provision must be maintained to
protect against avoidable hospital readmissions.
Cardiovascular risk factor control
Thirdly, the screening and management of cardiovascular risk factors
should continue during the COVID-19 pandemic. If not, this will only
increase demand for healthcare services in the future. Both diabetes
and hypertension have been associated with an increased risk of being
diagnosed with COVID-19,19 and poor glycaemic and blood pressure
control is known to affect immunity generally. Optimizing cardiovascu-
lar risk factors may therefore protect against more severe COVID-19
infections. To achieve this, technology needs to be used in innovative
ways. In many countries, primary care and cardiology services are
being delivered remotely through teleconsultations.20 In the face of
prolonged disruption to services, pragmatic approaches to the screen-
ing of patients are needed. For example, certain medical devices and
smartphone apps could be used to screen for arrhythmias.21 These
changes could trigger a fundamental shift in how we practice. To
ensure this feeds into wider digital health system development, ideally
evaluation mechanisms must be embedded into routine practice.
Conclusions
It is clear that COVID-19 will have a substantial economic impact on
healthcare systems. The acute pressure of managing the pandemic is
already responsible for a significant financial burden. However, lost
opportunities for the primary and secondary prevention of cardiovas-
cular disease will only exacerbate this by increasing future demand for
healthcare services. To mitigate against this risk, we argue that a com-
prehensive strategy to combat COVID-19 must include promoting
public health messages which are co-beneficial for protecting against
COVID-19 and the primary and secondary prevention of cardiovascu-
lar disease.
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